baber/WOPTO huggingface dataset:
Patent AU-2347500-A (AU)
Title: Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture ofa medicament for the treatment of glycolipid storage diseases
Inventor: JACOB GARY S
IPC: A61K31/445
Filed: 1999-12-08
Abstract: A novel method is disclosed for the treatment of a patient affected with Gaucher's disease or other such glycolipid storage diseases. The method comprises administering to said patient a therapeutically effective amount of a long-chain N-alkyl derivative of deoxynojirimycin to alleviate or inhibit the glycolipid storage disease. The long-chain alkyl group has from nine to about 20 carbon atoms and preferably is nonyl or decyl.
Patent AU-2573388-A (AU)
Title: An amphibious vehicle
Inventor: ALINO FRANCISCO JOSE LOPEZ-IBO
IPC: B63G8/00
Filed: 1988-11-21
Abstract: A two-level sea-land creeping vehicle formed by three main parts: a frustoconical bow portion which is movable independently but connected to the central part or compartment in the form of a drop of water, which is flat in the lower part and which is fixed with respect to the rear part which comprises the drive and steering assembly, as well as the breathing and safety zone. The vehicle is displaced on land by means of two rollers disposed in the lower region and by the drive of the motor, and it is likewise displaced on the surface of water due to its buoyancy and it is also displaced in a condition of dynamic immersion by the drive of the motor linked to positioning of the bow portion and hydroplanes; the air required is picked up from the surface by means of an appropriate telescopic arrangement and it has the particularity of not being hermetically sealed in the immersed condition. It is totally safe since it rises automatically to the surface when the motor stops.
Patent AU-2612699-A (AU)
Title: Human checkpoint kinase, hcds1, compositions and methods
Inventor: LUYTEN WALTER H M L
IPC: C12N5/10
Filed: 1998-10-21
Abstract: The invention provides for a novel human checkpoint kinase gene, hCDS1, comprising the nucleic acid sequence of residues 66-1694 of SEQ ID NO: 1, a protein expressed from the gene, fragments and functional equivalents of the protein. The invention also provides for pharmaceutical compositions comprising a hCDS1 protein, and methods utilizing the protein.
Patent AU-2664799-A (AU)
Title: Stable liquid mineral ascorbate compositions and methods of manufacture and use
Inventor: HEGENAUER JOHN C
IPC: A23L33/15
Filed: 1999-02-05
Abstract: Liquid vitamin C concentrate compositions comprise a mineral ascorbate and a pharmacologically acceptable liquid organic polyol solvent for the mineral ascorbate, the concentrate having a pH between about 5 and 7. The concentrate may also contain an aldonic compound and/or a pharmacologically acceptable zinc compound. The concentrate compositions are prepared by heating the solvent to 50-90° C. and mixing the ascorbate and/or aldonic compound and/or zinc compound into the heated solvent, preferably in the absence of oxygen. These concentrate compositions are also characterized as a composition which comprises the reaction product of a mineral ascorbate and a pharmacologically acceptable liquid organic polyol solvent and, optionally an aldonic compound and/or a soluble non-toxic zinc compound, which reaction product includes 4-hydroxy-5-methyl-3(2H)-furanone and/or 3-hydroxy kojic acid.Finished vitamin C products, characterized by excellent long term vitamin C stability, are conveniently prepared by incorporating the concentrates into finished cosmetic, medical and food products.
Patent AU-2665100-A (AU)
Title: Integrally asymmetrical polyolefin membrane
Inventor: KESSLER ERICH
IPC: B01D69/08
Filed: 2000-01-19
Abstract: Process for producing integrally asymmetrical hydrophobic polyolefinic membranes with a separation layer, in particular for gas exchange, via thermally induced liquid-liquid phase separation. A solution of at least one polyolefin in a solvent system containing a compound A and a compound B is extruded to form a shaped object. Compound A is a strong solvent and compound B a weak non-solvent for the polymer. After leaving the die, the shaped object is cooled using a solid or liquid cooling medium, which does not dissolve the polymer and does not react chemically with it, until the phase separation and solidification of the high-polymer-content phase take place. The integrally asymmetrical membrane producible in this manner has a porosity of greater than 30% to 75% by volume, a sponge-like, open-pored, microporous support layer without macrovoids and on average isotropic pores, a separation layer on at least one of its surfaces with pores <100 nm, if any, and a gas separation factor alpha(CO2/N2) of at least 1. The membrane is preferably used for blood oxygenation.
Patent AU-2858399-A (AU)
Title: A novel antimicrobial peptide isolated from (parasilurus asotus) and its uses
Inventor: KIM SUN CHANG
IPC: C07K7/08
Filed: 1999-03-22
Abstract: Disclosed is a novel antimicrobial peptide, named parasin I, which is isolated from catfish. Catfish produce a strong antimicrobial peptide in the epithelial mucosal layer upon epidermal injury to protect against the invasion of microorganisms. It is 2000.4 Da in molecular mass and consist of 19 amino acid residues, represented by Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser (SEQ ID NO: 1) Parasin I shows exceptionally potent antimicrobial activity against a broad spectrum of micrroorganisms, including Gram-positive and Gram-negative bacteria and fungui, without any hemolytic activity. Its synthetic derivatives also have potent activity. Therefore, parasin I and its derivatives can be used as wound healing agent, trauma curing agent, mouthwash, eyewash, etc.
Patent AU-2873400-A (AU)
Title: Felbamate derived compounds
Inventor: MACDONALD TIMOTHY L
IPC: C07D265/06
Filed: 2000-02-08
Abstract: The present invention relates to novel felbamate derivatives and their use to treat neurological diseases such as epilepsy and to treat tissue damage resulting form ischemic events. The felbamate derivatives are modified to prevent the formation of metabolites that are believed responsible for the toxicity associated with felbamate therapy.
Patent AU-2893999-A (AU)
Title: Surge anoxic mix sequencing batch reactor systems
Inventor: MANDT MIKKEL G
IPC: C02F3/34
Filed: 1999-03-03
Abstract: Wastewater treatment systems which utilize an interacting surge anoxic mix zone for facilitating nitrogen removal and an aerobic sequential batch reaction, clarification and decantation zone for facilitating aeration for BOD removal and nitrate production for the surge anoxic mix zone. Sludge reduction may also be accomplished by anaerobic recycle.
Patent AU-3001992-A (AU)
Title: Plasma ion nitrided stainless steel press plates and applications for same
IPC: B30B15/06
Filed: 1992-12-09
Abstract: A process and apparatus is disclosed for the fabrication of press plates hardened by the use of plasma ion nitriding techniques to produce wear resistant decorative laminate containing alumina grit while improving associated press plate useful life. The application of this process to press plates having exacting final microfinish requirements is possible due to the determination of interdependancies between parameter settings and expected results. These interdependancies include the work piece geometry, surface and subsurface structure and desired results, process temperatures, pressures, and duration of heat-up time, thermal loading, reflective radiation and heat effects, cooling systems, and gas mixture composition.
Patent AU-3133793-A (AU)
Title: Production and use of multimeric hemoglobins
IPC: C12N15/12
Filed: 1992-11-06
Abstract: Multimeric hemoglobin-like proteins are obtained by crosslinking cysteines, natural or artificial, of the component tetramers, or by genetically fusing globin-like domains of one tetramer with those of another, by means of an interdomain spacer sequence. Artificial cysteines are introduced selectively in a single globin-like domain per tetramer to control polymerization. <IMAGE>
Patent AU-3265095-A (AU)
Title: Process for production of methanediphosphonic acid compound
Inventor: KAWABE NORIO
IPC: C07F9/40
Filed: 1995-08-24
Abstract: A process for production of 1-alkylthiomethanediphosphonic acid compound or 1-arylthiomethanediphosphonic acid compound characterized by removing a thiolate byproduct as an insoluble salt, in the condensation represented by the following formula: <CHEM> wherein R'1 represents a linear or branched alkyl group having 1 to 6 carbon atoms, R2 represents an alkyl or aryl group, R1 represents a pharmaceutically allowable cation, hydrogen atom, or linear or branched alkyl group having 1 to 6 carbon atoms. The present invention significantly improves the yield compared with conventional methods, and simplifies the purification process at the same time, thus is extremely useful in an economical and industrial points of view.
Patent AU-3312093-A (AU)
Title: Device for conveying printed sheets in an installation for checking the quality of paper money
Inventor: ORLANDINI DANTE
IPC: G07D7/12
Filed: 1993-02-18
Abstract: The device comprises a transport chain (1) for the sheets to be monitored (3) by a detector (5). The support bars (4, 4') on which the sheet to be examined (3) slides are equipped, in the monitoring area, with suction nozzles (4a) and in the gap between two support bars (4) movable arms (10) are provided, equipped at their extremity with suction nozzles (10a) which, in operating position, are aligned with the suction nozzles (4a) of the support bars and arranged in the transfer plane of the sheets in order to hold the sheet to be examined (3) in this plane. In order to avoid the clips (2a) which pull the sheet (3) touching the arms (10), means are provided for tilting the said arms (10) when the clips (2a) pass above these arms.   <IMAGE>
Patent AU-3664084-A (AU)
Title: Bituminous composition
Inventor: MIKOLS WAYNE JOHN
IPC: C08L95/00
Filed: 1984-12-13
Abstract: The invention relates to a bituminous composition having improved stability and comprising:(a) 100-30%w of a mixture of(1) 40-99.8%w of a bituminous component having a penetration of less than 800 (0.1 mm) at 25 °C,(2) 0.1-50%w of a block copolymer having at least one thermoplastic monoalkenyl arene polymer block A and at least one elastomeric conjugated diene block B, and(3) 0.1-10.0%w of a polystyrene-poly(ethylene-propylene) diblock copolymer.(b) 0-70%w of a filler.
Patent AU-3791000-A (AU)
Title: Wooden trussed structural systems, such as frameworks, bridges, floors
Inventor: SANDOZ JEAN-LUC
IPC: E04C3/17
Filed: 1999-10-28
Abstract: A wooden trussed structure includes beams which are constructed from at least three elementary planks, nailed together. The plank located in the central part is offset relatively to the ends of the lateral planks, so as to form thereat, tenons and/or mortises for inserting, at the junction forming a node, a panel-type reinforcement, positioned in the core, and wherein the shearing surfaces correspond to the lateral surfaces at each node. The panel includes a wooden structural element such as a micro-lath or plywood as a plate-type solid web.
Patent AU-3960393-A (AU)
Title: Aerosol hair spray
IPC: A61K8/81
Filed: 1992-11-20
Abstract: Aerosol hair spray. Cosmetic hair composition in the form of an aerosol hair spray, containing (a) at least one soluble film-forming resin, (b) at least one plasticizing agent in a proportion of at least 10 % by weight compared with the weight of the resin, (c) water and (d) dimethylether as the propelling agent.
Patent AU-4200697-A (AU)
Title: Friction material, method of preparing same and friction lining
Inventor: KRAEMER OLE
IPC: F16D69/02
Filed: 1997-09-17
Abstract: PCT No. PCT/DK97/00391 Sec. 371 Date May 20, 1999 Sec. 102(e) Date May 20, 1999 PCT Filed Sep. 17, 1997 PCT Pub. No. WO98/12448 PCT Pub. Date Mar. 26, 1998A friction material comprising a sintered mass of iron in which graphite particles are dispersed, which sintered mass is formed from between 13 and 22 vol. % of iron fibers, between 13 and 22 vol. % of iron particles having a particle size of 10-400  mu m, between 40 and 70 vol. % of graphite particles having a particle size of 25-3000  mu m, and between 10 and 15 vol. % of a metallic binder having a melting point of 800-1140 DEG  C., and a method of preparing such a friction material, wherein a mixture of these components is compressed at a pressure of at least 100 MPa so as to form a compact having a desired form and size, and where the compact thus formed is sintered at a temperature between 800 and 1140 DEG  C. for a period of time which is sufficiently long for achieving concretion of iron fibers, iron particles and metallic binder.
Patent AU-4607899-A (AU)
Title: Ectoparasiticide agents
Inventor: JESCHKE PETER
IPC: A01N43/72
Filed: 1999-06-11
Abstract: The present invention relates to the ectoparasiticidal use of cyclic depsipeptides of the formula (I)in whichR<1>, R<2>, R<3>, R<4>, X<1>, X<2>, X<3 >and X<4 >are substituents described herein, which are effective for controlling ectoparasites, and to ectoparasiticidal compositions containing the depsipeptides.
Patent AU-4652300-A (AU)
Title: Shot-gun sequencing and amplification without cloning
Inventor: SENAPATHY PERIANNAN
IPC: C12Q1/68
Filed: 2000-04-20
Abstract: Disclosed is a method for sequencing and amplifying nucleic acid templates wherein a degenerate primer with a fixed sequence region and a random sequence region is utilized. By determining the statistical expectancy of the fixed sequence in the nucleic acid template, this determines the average length of a nucleic acid template that can be sequenced. During the annealing of such a primer with the nucleic acid template, the fixed sequence determines where the complete primer binds by binding to its complementary sequence on the nucleic acid template. The random sequence regions of the primers make it possible for the presence of a unique sequence adjacent to the fixed sequence to be present, thus providing a primer with full complementarity with the nucleic acid template. Thus, this procedure is able to provide a full-length primer with a fully complementary sequence capable of binding statistically once within an expected length of the nucleic acid template, even though the sequence of the template is unknown. The method can also be adopted for use in PCR amplification of a nucleic acid template.
Patent AU-4687699-A (AU)
Title: Apparatus for holding contact lens care composition and contact lens case
Inventor: DRIES JOHN W VANDEN
IPC: B65D23/12
Filed: 1999-06-18
Abstract: Apparatus comprising first and second containers for holding contact lens care compositions and contact lens cases, respectively. The first container defines a chamber adapted to hold contact lens care composition and has an outlet. The second container defines a compartment and is adapted to be removably secured to the first container such that the second container extends outwardly away from the first container with the second container removably secured to the first container. A closure assembly is preferably provided and is coupled to the outlet of the first container. The closure assembly includes a passageway in fluid communication with the outlet and is adapted to provide for egress of the contact lens care composition from the chamber. A cap member is adapted to be moved between an open position in which the passageway is open and a closed position in which the passageway is closed.
Patent AU-4811399-A (AU)
Title: Hydrogel product for adsorption purposes
Inventor: PORATH JERKER
IPC: B01J20/32
Filed: 1999-06-08
Abstract: The present invention relates to a hydrogel product for adsorption where an in water non-soluble support matrix is cross-linked with polymers which give rise to an in water swellable adsorbent. As support matrix an organic polymer or a combination of such are used, e.g. polysaccharide such as agar, cellulose, starch among other things, protein and components of protein and polysaccharide. The support matrix is substituted with a first, soluble polymer material chemically bound to the support matrix, whereupon additional polymer material are built in the primary synthesized support matrix polymer complex through different kinds of cross-links whereby optionally the support matrix is present in the form of an acid- and base-stable residue.
Patent AU-4831900-A (AU)
Title: Adjustable vehicle control pedals
Inventor: WILLEMSEN LARRY G
IPC: G05G1/405
Filed: 2000-05-10
Abstract: An adjustable control pedal apparatus is used in a motor vehicle. The pedal apparatus includes a pedal assembly mounted to a support bracket mounted to the vehicle by a pivot shaft. The pivot shaft contains a worm gear. The pedal assembly includes a pedal arm pivotally mounted to an inner arm. A jack screw extends between the inner arm and pedal arm. The jack screw has a pinion portion on one end which is driven by the worm gear of the pivot shaft. A threaded portion of the jack screw is threadably received in a slide block mounted to the pedal arm. Rotation of the pivot shaft by a motor correspondingly turns the jack screw to adjust the position of the pedal.
Patent AU-4893797-A (AU)
Title: A process for the recovery of lactic acid
Inventor: EYAL AHARON MEIR
IPC: C07C51/47
Filed: 1997-10-02
Abstract: The invention provides a process for the recovery of purified lactic acid values from an aqueous feed solution containing lactic acid, lactic acid salt, or mixtures thereof, comprising: bringing the feed solution into contact with a substantially immiscible anion exchanger to form a substantially water-immiscible phase comprising an anion exchanger-lactic acid adduct; effecting a condensation reaction in the substantially water-immiscible phase between a carboxylic moiety of the lactic acid adduct and a moiety selected from a hydroxyl moiety and a primary or secondary amine moiety to respectively form a lactic acid ester or amine product; and separating the formed lactic acid product from the anion exchanger.
Patent AU-5116401-A (AU)
Title: Methods and apparatus for diagnositic multispectral digital imaging
Inventor: UTZINGER URS
IPC: G01N21/27
Filed: 2001-03-28
Abstract: Methods and apparatus for generating multispectral images of tissue. The multispectral images may be used as a diagnostic tool for conditions such as cervical cancer detection and diagnosis. Primary radiation is produced with an illumination source. The primary radiation is filtered to select a first wavelength and a first polarization. Tissue is illuminated with the filtered primary radiation to generate secondary radiation, which is filtered to select a second wavelength and a second polarization. The filtered secondary radiation is collected with a detector, and a plurality of multispectral images of the tissue is generated according to different combinations of first and second wavelengths and first and second polarization with an analysis unit in operable relation with the detector. Apparatus utilizing the invention include endoscopes and colposcopes.
Patent AU-5256001-A (AU)
Title: Method for refrigerant and oil collecting operation and refrigerant and oil collection controller
Inventor: TAIRA SHIGEHARU
IPC: F25B43/02
Filed: 2001-04-25
Abstract: A method for refrigerant and oil collecting operation capable of assuring the cleanliness of the inside of an existing communication pipe at a low cost and installing, at a low cost, a new air conditioner, comprising a compressor (1), a heat source side heat exchanger (3), a decompressing mechanism (4), and a user side heat exchanger (5), comprising the steps of performing a pipe heating operation in a heating operation mode and performing a refrigerant and oil collecting operation to collect refrigerant to a heat source side heat exchanger (3), namely, with the refrigerant heated to a temperature higher than that where contaminants such as refrigerator oil inside a refrigerant circuit is dissolved into the refrigerant, performing the refrigerant and oil collecting operation so as to assure the cleanliness of the inside of the existing communication pipes (7, 8). <IMAGE>
Patent AU-5265600-A (AU)
Title: Nanotube-based high energy material and method
Inventor: ZHOU OTTO Z
IPC: C01B31/02
Filed: 2000-02-24
Abstract: A carbon-based material containing an allotrope of carbon, such as single-walled carbon nanotubes, is capable of accepting and intercalated alkali metal. The material exhibits a reversible capacity ranging from approximately 650 mAh/g-1,000 mAh/g. The high capacity of the material makes it attractive for a number of applications, such as a battery electrode material. A method of producing a single-walled carbon nanotube material includes purifying an as-recovered nanotube material, and depositing the purified material onto a conductive substrate. The coated substrate is incorporated into an electrochemical cell, an its ability to accept intercalated materials, such as an alkali metal (e.g.-lithium) is measured.
Patent AU-5340694-A (AU)
Title: Biocidal chitin binding proteins
Inventor: BROEKAERT WILLEM FRANS
IPC: C12N5/10
Filed: 1993-10-22
Abstract: Biocidal proteins capable of isolation from seeds have been characterised. The proteins have an amino acid sequence containing the common cysteine/glycine domain of Chitin-binding Plant Proteins but show substantially better activity against pathogenic fungi, a higher ratio of basic amino acids to acidic amino acids, and/or antifungal activity which results in increased hyphal branching. Antimicrobial proteins isolated from Capsicum, Briza and related species are provided. The proteins show a wide range of antifungal activity and are active against Gram-positive bacteria. DNA encoding the proteins may be isolated and incorporated into vectors. Plants may be transformed with this DNA. The proteins find agricultural or pharmaceutical application as antifungal or antibacterial agents. Transgenic plants expressing the protein will show increased disease resistance.
Patent AU-5519590-A (AU)
Title: Amino acid derivative anticonvulsant
Inventor: KOHN HAROLD L
IPC: A61K31/5375
Filed: 1990-05-18
Abstract: The present invention relates to compounds exhibiting central nervous system (CNS) activity which are useful in the treatment of epilepsy and other CNS disorders. The compounds of this invention have the following general formula: <CHEM>  and pharmaceutically acceptable salts thereof wherein R is aryl, aryl lower alkyl, heterocyclic or heterocyclic lower alkyl, wherein R is unsubstituted or is substituted with at least one electron withdrawing group or an electron donating group; R1 is hydrogen or lower alkyl and R1 is unsubstituted or is substituted with at least one electron withdrawing substituent or at least one electron donating substituent; R2 and R3 are independently each hydrogen, lower alkenyl, lower alkynyl, aryl lower alkyl, aryl, heterocycli, heterocycli lower alkyl or Z-Y, wherein R2 and R3 may be unsubstituted or substituted with at least one electron withdrawing group or electron donating group;  Z is O, S, NR4, PR4 or a chemical bond; Y is hydrogen, lower alkyl, aryl, aryl lower alkyl, lower alkenyl, lower alkynyl, or halo, and Y may be unsubstituted or substituted with at least one electron donating group or electron donating group; provided that when Y is halo, Z is a chemical bond or ZY taken together is NR4NR5R6, NR4OR5, ONR4R5, OPR4R5, PR4OR5, SNR4R5, NR4SR5, SPR4R5, PR4SR5, NR4PR5R6 or PR4NR5R6, R4, R5 and R6 are independently hydrogen, lower alkyl, aryl, aryl lower alkyl, lower alkenyl, lower alkynyl, and R4, R5 and R6 may be unsubstituted or substituted with an electron withdrawing group or an electron donating group and n is 1-4. u